EvergreenHealth (Site 1080), 12040 NE 128th Street, Ste MS-77 — Kirkland, Washington

EvergreenHealth (Site 1080), 12040 NE 128th Street, Ste MS-77 is a clinical research site located in Kirkland, Washington, United States 98034-3013.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

EvergreenHealth (Site 1080), 12040 NE 128th Street, Ste MS-77 has participated in 1 clinical trials.

Therapeutic areas: Coronavirus, Covid19.

Sponsors: National Institute of Allergy and Infectious Diseases (NIAID).

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Kirkland

Browse all research sites in Washington · View every site in Kirkland

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for EvergreenHealth (Site 1080), 12040 NE 128th Street, Ste MS-77?

EvergreenHealth (Site 1080), 12040 NE 128th Street, Ste MS-77 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has EvergreenHealth (Site 1080), 12040 NE 128th Street, Ste MS-77 conducted?

EvergreenHealth (Site 1080), 12040 NE 128th Street, Ste MS-77 has 1 clinical trials on record. Their work covers Coronavirus, Covid19.

Is EvergreenHealth (Site 1080), 12040 NE 128th Street, Ste MS-77 accredited by Crixeo Clinical Trials?

EvergreenHealth (Site 1080), 12040 NE 128th Street, Ste MS-77 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about EvergreenHealth (Site 1080), 12040 NE 128th Street, Ste MS-77?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.